Costs
Part of Healthcare Marketing Compliance Guide for Clinics
How to Define Healthcare Marketing Compliance Benchmarks
How to define healthcare marketing compliance benchmarks: name the measure, owner, numerator, denominator, period and source, set targets from your baseline.
What to take away
- Healthcare marketing compliance benchmarks should show whether the system prevents, detects, contains, and remediates material failures. Activity counts do not.
- Define each measure with an owner, numerator, denominator, period, source system, exclusions, and a target rationale before you collect anything.
- No credible cross-organization numeric target exists for most of these measures. Set yours from your own baseline and your own risk assessment.
- Balance speed and volume measures against quality, recurrence, harm, and independent retest.
- Seven starter measuresreview turnaround time, pre-publication defect rate, high-risk decision currency, training decision accuracy, overdue corrective actions, recurrence, and regulatory inquiry response — are defined below.
- Review every definition after a change in rule, risk, vendor, audience, or platform.
Define each measure before you collect data
A benchmark earns its place only when a second person can recompute it from the same source and reach the same number. Write the definition down first. Then start counting.
The healthcare marketing compliance guide on this site sets out which obligations generate the risk a benchmark is meant to watch. Benchmarks sit on top of that work. They do not replace it.
These measures only matter because named rules create the risk. FDA regulates prescription drug advertising and promotional labeling directed to healthcare professionals and consumers under section 502(a) and (n) of the FD&C Act, while the Federal Trade Commission regulates the advertising of non-prescription drug products. The FDA office that handles prescription drug promotion describes its mission as helping to ensure that prescription drug information is truthful, balanced, and accurately communicated. Patient data used in a campaign adds HIPAA duties on top. Those are the FDA and FTC advertising rules a review queue is really testing.
Benchmarks worth defining first
Seven starter measures cover the obligations most practices carry:
- Review turnaround time:median calendar days from submission to final approval, taken from the review queue with the same start and stop events each period.
- Pre-publication defect rate:public items the reviewer flags as material, divided by all public items reviewed in the period.
- High-risk decisions made with current instructions:decisions on the risk register that cite the current approved instruction set, divided by all high-risk decisions in the period.
- Training completion with decision accuracy:staff who complete required training and pass a post-training scenario check, reported beside completion alone.
- Overdue corrective actions:corrective actions past their agreed due date, divided by all open corrective actions.
- Recurrence rate:material issues that recur within the review window after closure, divided by all closed material issues.
- Regulatory inquiry response:inquiries from a regulator, payer, or platform answered completely and by the stated deadline, divided by all such inquiries received in the period.
Give each one a target rationale rather than a borrowed number: state what a better figure would change in a decision, and who would act on it.
Example: a pre-publication review measure
Pre-publication review measure
- Owner
- Marketing compliance lead, named in the measure register
- Numerator
- Public items the reviewer flags as material and a second reviewer confirms
- Denominator
- Public-facing items reviewed before publication in the period
- Period
- Calendar month, closed on the fifth business day
- Source system
- Version-locked review queue export, not a hand tally
- Exclusions
- Repeats of an item counted in an earlier period
- Target rationale
- Prior twelve-month baseline, adjusted for a stated reduction in confirmed defects
- Decision
- Confirmed defects go to weekly triage; a threshold breach triggers review of the intake form
That field set is the guard against drift. Change the reviewer, the flag rule, or the queue and the series breaks. A comparison between months then shows a trend that is not there.
Which measures match each program element
The HCCA OIG compliance effectiveness resource guide, Measuring Compliance Program Effectiveness: A Resource Guide, issued in 2017, offers a menu of measurement ideas across the seven elements of an effective compliance program: policies and procedures; program administration; screening and evaluation of employees, physicians, vendors, and other agents; communication, education, and training; monitoring, auditing, and internal reporting; discipline for non-compliance; and investigations and remedial measures. Its introduction says the list is not a checklist to apply wholesale. Using all or even many of them is impractical, so pick what your risk assessment supports.
Measures by program element
| Element | Measure to consider | Guardrail |
|---|---|---|
| Policies | High-risk decisions made with current instructions | Observed use, exception quality |
| Administration | Material issues reaching an empowered owner | Resources, independence, closure |
| Screening | Required checks completed before access | Scope, timeliness, false matches, retest |
| Training | Scenario decisions performed correctly | Later work samples, role relevance |
| Monitoring | Live defects found by defined tests | Coverage, severity, blind spots |
| Response | Findings remediated and independently retested | Recurrence, affected copies, open risk |
Treat each phrase in that table as a starting point, not a benchmark. "High-risk decisions made with current instructions" becomes usable only when you write it out: which decisions count, who confirms the current instruction set, which register supplies the denominator, and which source system can prove it. Discipline for non-compliance is the seventh element the table leaves out, and it needs its own measure, such as cases closed with a documented, consistent action divided by cases where discipline was warranted.
Where credible numbers come from
This article gives no numeric industry benchmark values. For most of these measures no credible cross-organization number exists. Start with your own twelve-month baseline, then cite the OIG and HCCA resource guide, the GAO Green Book criteria, or a published CMS quality measure when you need an outside reference point.
The GAO Green Book sets internal-control criteria for federal agencies across control environment, risk assessment, control activities, information and communication, and monitoring. A clinic may borrow the structure. It cannot claim the Green Book certifies its marketing program. A practical compliance routine turns those criteria into a weekly habit.
Guard against gameable targets
- Zero reported issues can mean weak trust or poor detection
- Fast approvals can mean incomplete review
- One hundred percent training completion can sit beside poor decisions
- Few findings can reflect narrow audit coverage
- Fast closure can hide incomplete remediation
Report high-risk unknowns and overdue remediation instead of dropping them from the dashboard. A program that launched cleanly can still drift, so keeping it honest after launch deserves its own review.
Set the review cadence
- Record the definition and the owner in the measure register.
- Set the next review date and name the triggers that move it earlier.
- Recompute the figure from the source before comparing periods.
- Show counts beside rates and distributions, because averages conceal failures.
- Retire a measure when no decision depends on it.
The GAO evaluation design guide ties evaluation questions to evidence needs and design choices. Use that discipline to separate benchmark reporting from effect estimates. A local marketing result stays local unless the design supports more. Teams that keep a written record of recurring compliance questions argue less about definitions each quarter.
Common questions
What is a good compliance benchmark?
A measure is good when it is defined, tied to a material decision, resistant to gaming, and reported with the quality and risk context that explains it. Reproducibility matters more than precision.
Should we adopt every measure in the OIG and HCCA resource guide?
No. The guide itself advises a practical subset matched to your program. Start with the risks your last assessment ranked highest.
How often should benchmarks change?
Review after any change in rule, risk, product, audience, data, vendor, platform, incident, or control. Review sooner if a measure starts driving behavior you did not intend.
